Skip to main content
Top
Published in: BMC Gastroenterology 1/2023

Open Access 01-12-2023 | Liver Transplantation | Research article

International survey among hepatologists and pulmonologists on the hepatic hydrothorax: plea for recommendations

Authors: Jean-François David Cadranel, Isabelle Ollivier-Hourmand, Jacques Cadranel, Thierry Thevenot, Honoré Zougmore, Eric Nguyen-Khac, Christophe Bureau, Manon Allaire, Jean-Baptiste Nousbaum, Véronique Loustaud-Ratti, Xavier Causse, Philippe Sogni, Bertrand Hanslik, Marc Bourliere, Jean-Marie Peron, Nathalie Ganne-Carrie, Thong Dao, Dominique Thabut, Bernard. Maitre, Nabil Debzi, Ryad Smadhi, Roger Sombie, Raimi Kpossou, Olivier Nouel, Julien Bissonnette, Isaac Ruiz, Mourad Medmoun, Sergio Negrin Dastis, Pierre Deltenre, Florent Artru, Chantal Raherison, Laure Elkrief, Tristan Lemagoarou

Published in: BMC Gastroenterology | Issue 1/2023

Login to get access

Abstract

Background

The Hepatic hydrothorax is a pleural effusion related to portal hypertension; its diagnosis and therapeutic management may be difficult. The aims of this article are which follows: To gather the practices of hepatogastroenterologists or pulmonologists practitioners regarding the diagnosis and management of the hepatic hydrothorax.

Methods

Practitioners from 13 French- speaking countries were invited to answer an online questionnaire on the hepatic hydrothorax diagnosis and its management.

Results

Five hundred twenty-eight practitioners (80% from France) responded to this survey. 75% were hepatogastroenterologists, 20% pulmonologists and the remaining 5% belonged to other specialities. The Hepatic hydrothorax can be located on the left lung for 64% of the responders (66% hepatogastroenterologists vs 57% pulmonologists; p = 0.25); The Hepatic hydrothorax can exist in the absence of clinical ascites for 91% of the responders (93% hepatogastroenterologists vs 88% pulmonologists; p = 0.27). An Ultrasound pleural scanning was systematically performed before a puncture for 43% of the responders (36% hepatogastroenterologists vs 70% pulmonologists; p < 0.001). A chest X-ray was performed before a puncture for 73% of the respondeurs (79% hepatogastroenterologists vs 54% pulmonologists; p < 0.001). In case of a spontaneous bacterial empyema, an albumin infusion was used by 73% hepatogastroenterologists and 20% pulmonologists (p < 0.001). A drain was used by 37% of the responders (37% hepatogastroenterologists vs 31% pulmonologists; p = 0.26).An Indwelling pleural catheter was used by 50% pulmonologists and 22% hepatogastroenterologists (p < 0.01). TIPS was recommended by 78% of the responders (85% hepatogastroenterologists vs 52% pulmonologists; p < 0.001) and a liver transplantation, by 76% of the responders (86% hepatogastroenterologists vs 44% pulmonologists; p < 0.001).

Conclusions

The results of this large study provide important data on practices of French speaking hepatogastroenterologists and pulmonologists; it appears that recommendations are warranted.
Appendix
Available only for authorised users
Literature
1.
go back to reference Badillo R, Rockey DC. Hepatic hydrothorax: clinical features, management, and outcomes in 77 patients and review of the literature. Medecine. 2014;93:135–42.CrossRef Badillo R, Rockey DC. Hepatic hydrothorax: clinical features, management, and outcomes in 77 patients and review of the literature. Medecine. 2014;93:135–42.CrossRef
2.
go back to reference Cadranel JF, Jouannaud V, Duron JJ. Complications pleuropulmonaires : comment traiter les complications pleuropulmonaires ? Prise en charge d’un hydrothorax hépatique. Gastroenterol Clin Biol. 2004;28:B287–300 PMID :15150525.CrossRefPubMed Cadranel JF, Jouannaud V, Duron JJ. Complications pleuropulmonaires : comment traiter les complications pleuropulmonaires ? Prise en charge d’un hydrothorax hépatique. Gastroenterol Clin Biol. 2004;28:B287–300 PMID :15150525.CrossRefPubMed
3.
go back to reference Cadranel JF, Garioud A, Lison H, Medmoun M, Thevenot T. Hepatic Hydrothorax. Presse Med. 2016;45(10):815–23 PMID: 27242207.CrossRefPubMed Cadranel JF, Garioud A, Lison H, Medmoun M, Thevenot T. Hepatic Hydrothorax. Presse Med. 2016;45(10):815–23 PMID: 27242207.CrossRefPubMed
4.
go back to reference Lieberman FL, Hidemura R, Peters RL, Reynolds TB. Pathogenesis and treatment of hydrothorax complicating cirrhosis with ascites. Ann Intern Med. 1966;64:341–51 PMID :5902279.CrossRefPubMed Lieberman FL, Hidemura R, Peters RL, Reynolds TB. Pathogenesis and treatment of hydrothorax complicating cirrhosis with ascites. Ann Intern Med. 1966;64:341–51 PMID :5902279.CrossRefPubMed
6.
go back to reference Lazaridis KN, Frank JW, Krowka MJ, Kamath PS. Hepatic hydrothorax : pathogenesis, diagnosis, and management. Am J Med. 1999;107:262–7 PMID :10492320.CrossRefPubMed Lazaridis KN, Frank JW, Krowka MJ, Kamath PS. Hepatic hydrothorax : pathogenesis, diagnosis, and management. Am J Med. 1999;107:262–7 PMID :10492320.CrossRefPubMed
7.
go back to reference Giacobbe A, Facciorusso D, Tonti P, et al. Hydrothorax complicating cirrhosis in the absence of ascites. J Clin Gastroenterol. 1993;16:271–2 PMID :8228096.CrossRef Giacobbe A, Facciorusso D, Tonti P, et al. Hydrothorax complicating cirrhosis in the absence of ascites. J Clin Gastroenterol. 1993;16:271–2 PMID :8228096.CrossRef
9.
go back to reference Thevenot T, Cadranel JF, Di Martino V, et al. A national French survey on the use of growth factors as adjuvant treatment of chronic hepatitis C. Hepatology. 2007;45:377–83.CrossRefPubMed Thevenot T, Cadranel JF, Di Martino V, et al. A national French survey on the use of growth factors as adjuvant treatment of chronic hepatitis C. Hepatology. 2007;45:377–83.CrossRefPubMed
10.
go back to reference Thevenot T, Degand T, Grelat N, et al. National Association of General Hospital Hepatogastroenterologists. A French national survey on the use of antibiotic prophylaxis in cirrhotic patients. Liver Int. 2013;33:389–97.CrossRefPubMed Thevenot T, Degand T, Grelat N, et al. National Association of General Hospital Hepatogastroenterologists. A French national survey on the use of antibiotic prophylaxis in cirrhotic patients. Liver Int. 2013;33:389–97.CrossRefPubMed
11.
go back to reference Garioud G, Cadranel JF, Nousbaum JB, Thevenot T, Dao T, Louvet A, et al. Albumin Use in Patients With Cirrhosis in France : Results of the « ALBU-LIVE » Survey. A Case for Better EASL Guidelines Diffusion and/or Revision. J Clin Gastroenterol. 2017;51(9):831–8. https://doi.org/10.1097/MCG.0000000000000735. Garioud G, Cadranel JF, Nousbaum JB, Thevenot T, Dao T, Louvet A, et al. Albumin Use in Patients With Cirrhosis in France : Results of the « ALBU-LIVE » Survey. A Case for Better EASL Guidelines Diffusion and/or Revision. J Clin Gastroenterol. 2017;51(9):831–8. https://​doi.​org/​10.​1097/​MCG.​0000000000000735​.
12.
go back to reference Ajmi S, Hassine H, Guezguez M, et al. Isotopic exploration of hepatic hydrothorax : ten cases. Gastroenterol Clin Biol. 2004;28:462–6 PMID :15243321.CrossRefPubMed Ajmi S, Hassine H, Guezguez M, et al. Isotopic exploration of hepatic hydrothorax : ten cases. Gastroenterol Clin Biol. 2004;28:462–6 PMID :15243321.CrossRefPubMed
13.
go back to reference Shojaee S, Khalid M, Kallingal G, Kang L, Rahman N. Repeat thoracentesis in hepatic hydrothorax and non-hepatic hydrothorax Effusions : a case-control study. Respiration. 2018;96:330–7.CrossRefPubMed Shojaee S, Khalid M, Kallingal G, Kang L, Rahman N. Repeat thoracentesis in hepatic hydrothorax and non-hepatic hydrothorax Effusions : a case-control study. Respiration. 2018;96:330–7.CrossRefPubMed
14.
go back to reference Xiol C, Castellote J, Cortes-Beut R, et al. Usefulness and complications oh thoracentesis in cirrhotic patients. Am J Med. 2001;111:67–9 PMID :11448663.CrossRefPubMed Xiol C, Castellote J, Cortes-Beut R, et al. Usefulness and complications oh thoracentesis in cirrhotic patients. Am J Med. 2001;111:67–9 PMID :11448663.CrossRefPubMed
15.
go back to reference Xiol X, Castellote J, Guardiola J, et al. Spontaneous bacterial empyema in cirrhotic patients : a prospective study. Hepatology. 1996;23:719–23 PMID :8666323.CrossRefPubMed Xiol X, Castellote J, Guardiola J, et al. Spontaneous bacterial empyema in cirrhotic patients : a prospective study. Hepatology. 1996;23:719–23 PMID :8666323.CrossRefPubMed
16.
go back to reference Cardenas A, Kelleher T, Chopra S. Review article : hepatic hydrothorax. Aliment Pharmacol Ther. 2004;20:271–9 PMID :15274663.CrossRefPubMed Cardenas A, Kelleher T, Chopra S. Review article : hepatic hydrothorax. Aliment Pharmacol Ther. 2004;20:271–9 PMID :15274663.CrossRefPubMed
17.
go back to reference Gur C, Ilan Y, Shibolet O. Hepatic hydrothorax-pathophysiology, diagnosis and treatment-review of literature. Liver Int. 2004;24:281–4 PMID :15287850.CrossRefPubMed Gur C, Ilan Y, Shibolet O. Hepatic hydrothorax-pathophysiology, diagnosis and treatment-review of literature. Liver Int. 2004;24:281–4 PMID :15287850.CrossRefPubMed
18.
go back to reference Runyon BA, Practice Guidelines Committee AASLD. Management of adult patients with ascites due to cirrhosis. Hepatology. 2004;39:841–56.CrossRefPubMed Runyon BA, Practice Guidelines Committee AASLD. Management of adult patients with ascites due to cirrhosis. Hepatology. 2004;39:841–56.CrossRefPubMed
20.
go back to reference Liu L, Haddadin H, Bodian C, et al. Outcome analysis of cirrhotic patients undergoing chest tube placement. Chest. 2004;126:142–8 PMID : 15249455.CrossRefPubMed Liu L, Haddadin H, Bodian C, et al. Outcome analysis of cirrhotic patients undergoing chest tube placement. Chest. 2004;126:142–8 PMID : 15249455.CrossRefPubMed
21.
go back to reference Ridha A, Al-Abboodi Y, Fasullo M. The Outcome of thoracentesis versus chest tube placement for hepatic hydrothorax in patients with Cirrhosis : a nationwide analysis of the national inpatient sample. Gastroenterol Res Pract. 2017;2017:5872068.CrossRefPubMedPubMedCentral Ridha A, Al-Abboodi Y, Fasullo M. The Outcome of thoracentesis versus chest tube placement for hepatic hydrothorax in patients with Cirrhosis : a nationwide analysis of the national inpatient sample. Gastroenterol Res Pract. 2017;2017:5872068.CrossRefPubMedPubMedCentral
22.
go back to reference Runyon BA, Aasid. Introduction of the revised American association for the study of liver diseases practice guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013;57:1651–3.CrossRefPubMed Runyon BA, Aasid. Introduction of the revised American association for the study of liver diseases practice guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013;57:1651–3.CrossRefPubMed
23.
go back to reference Ferrante D, Arguedas MR, Cerfolio RJ, et al. Video-assisted thoracoscopic surgery with talc pleurodesis in the management of symptomatic hepatic hydrothorax. Am J Gastroenterol. 2002;97:3172–5 PMID : 12492206.CrossRefPubMed Ferrante D, Arguedas MR, Cerfolio RJ, et al. Video-assisted thoracoscopic surgery with talc pleurodesis in the management of symptomatic hepatic hydrothorax. Am J Gastroenterol. 2002;97:3172–5 PMID : 12492206.CrossRefPubMed
24.
go back to reference de MilanezCampos JR, Filho LO, de WerebeCampos E, et al. Thoracoscopy and talc poudrage in the management of hepatic hydrothorax. Chest. 2000;118:13–7 PMID : 10893352.CrossRef de MilanezCampos JR, Filho LO, de WerebeCampos E, et al. Thoracoscopy and talc poudrage in the management of hepatic hydrothorax. Chest. 2000;118:13–7 PMID : 10893352.CrossRef
25.
go back to reference Chen A, Massoni J, Jung D, Crippin J. Indwelling Tunneled Pleural Catheters for the management of hepatic Hydrothorax. A Pilot Study. Ann Am Thorac Soc. 2016;13:862–6.CrossRefPubMed Chen A, Massoni J, Jung D, Crippin J. Indwelling Tunneled Pleural Catheters for the management of hepatic Hydrothorax. A Pilot Study. Ann Am Thorac Soc. 2016;13:862–6.CrossRefPubMed
26.
go back to reference Kniese C, Diab K, Ghabril M, Bosslet G. Indwelling pleural catheters in hepatic Hydrothorax : a single-center series of outcomes and complications. Chest. 2019;155:307–14.CrossRefPubMed Kniese C, Diab K, Ghabril M, Bosslet G. Indwelling pleural catheters in hepatic Hydrothorax : a single-center series of outcomes and complications. Chest. 2019;155:307–14.CrossRefPubMed
27.
go back to reference Shojaee S, Rahman N, Haas K, Kern R, Leise M, Alnijoumi M, Lamb C, et al. Indwelling tunneled pleural catheters for refractory hepatic hydrothorax in patientswith cirrhosis : a Multicenter study. Chest. 2019;155:546–53.CrossRefPubMed Shojaee S, Rahman N, Haas K, Kern R, Leise M, Alnijoumi M, Lamb C, et al. Indwelling tunneled pleural catheters for refractory hepatic hydrothorax in patientswith cirrhosis : a Multicenter study. Chest. 2019;155:546–53.CrossRefPubMed
28.
go back to reference Gordon FD, Anastopoulos HT, Crenshaw W, et al. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology. 1997;25:1366–9 PMID : 9185754.CrossRefPubMed Gordon FD, Anastopoulos HT, Crenshaw W, et al. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology. 1997;25:1366–9 PMID : 9185754.CrossRefPubMed
29.
go back to reference Jeffries M, Kazanjian S, Wilson M, et al. Transjugular Intrahepatic Portosystemic Shunts and Liver Transplantation in Patients With Refractory Hepatic Hydrothorax. Liver Transpl Surg. 1998;4:416–23 PMID : 9724480.CrossRefPubMed Jeffries M, Kazanjian S, Wilson M, et al. Transjugular Intrahepatic Portosystemic Shunts and Liver Transplantation in Patients With Refractory Hepatic Hydrothorax. Liver Transpl Surg. 1998;4:416–23 PMID : 9724480.CrossRefPubMed
30.
go back to reference Spencer EB, Cohen DT, Darcy MD. Safety and Efficacy of Transjugular Intrahepatic Portosystemic Shunt Creation for the Treatment of Hepatic Hydrothorax. J Vasc Interv Radiol. 2002;13:385–90 PMID : 11932369.CrossRefPubMed Spencer EB, Cohen DT, Darcy MD. Safety and Efficacy of Transjugular Intrahepatic Portosystemic Shunt Creation for the Treatment of Hepatic Hydrothorax. J Vasc Interv Radiol. 2002;13:385–90 PMID : 11932369.CrossRefPubMed
31.
go back to reference Siegerstetter V, Deibert P, Ochs A, et al. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt : long-term results in 40 patients. Eur J Gastroenterol Hepatol. 2001;13:529–34 PMID : 11396532.CrossRefPubMed Siegerstetter V, Deibert P, Ochs A, et al. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt : long-term results in 40 patients. Eur J Gastroenterol Hepatol. 2001;13:529–34 PMID : 11396532.CrossRefPubMed
32.
go back to reference Strauss RM, Martin LG, Kaufman SL, et al. Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax. Am J Gastroenterol. 1994;89:1520–2 PMID : 8079930.PubMed Strauss RM, Martin LG, Kaufman SL, et al. Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax. Am J Gastroenterol. 1994;89:1520–2 PMID : 8079930.PubMed
33.
go back to reference Ditah IC, Al Bawardy BF, Saberi B, Ditah C, Kamath PS. Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax : a systematic review and cumulative meta-analysis. World J Hepatol. 2015;7:1797–806.CrossRefPubMedPubMedCentral Ditah IC, Al Bawardy BF, Saberi B, Ditah C, Kamath PS. Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax : a systematic review and cumulative meta-analysis. World J Hepatol. 2015;7:1797–806.CrossRefPubMedPubMedCentral
34.
go back to reference Bureau C, Thabut D, Jezequel C, Archambeaud I, D’Alteroche L, Dharancy S, et al. The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : a Randomized Controlled Trial. Ann Intern Med. 2021;174(5):633–40. https://doi.org/10.7326/M20-0202. Epub 2021 Feb 2.CrossRefPubMed Bureau C, Thabut D, Jezequel C, Archambeaud I, D’Alteroche L, Dharancy S, et al. The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : a Randomized Controlled Trial. Ann Intern Med. 2021;174(5):633–40. https://​doi.​org/​10.​7326/​M20-0202. Epub 2021 Feb 2.CrossRefPubMed
36.
go back to reference Xiol X, Tremosa G, Castellote J, et al. Liver transplantation in patients with hepatic hydrothorax. Transplant Int. 2005;18:672 PMID : 15910292.CrossRef Xiol X, Tremosa G, Castellote J, et al. Liver transplantation in patients with hepatic hydrothorax. Transplant Int. 2005;18:672 PMID : 15910292.CrossRef
37.
go back to reference Mohamed A, Atef M, Alsebaey A, Musa Elhabshy M, Salama M. Combined spontaneous bacterial empyema and peritonitis in cirrhotic patients with ascites and hepatic hydrothorax. Arab J Gastroenterol. 2017;18:104–7.CrossRefPubMed Mohamed A, Atef M, Alsebaey A, Musa Elhabshy M, Salama M. Combined spontaneous bacterial empyema and peritonitis in cirrhotic patients with ascites and hepatic hydrothorax. Arab J Gastroenterol. 2017;18:104–7.CrossRefPubMed
39.
go back to reference Huang PM, Kuo SW, Chen JS, Lee JM. Thoracoscopic mesh repair of diaphragmatic defects in hepatic Hydrothorax : a 10-year experience. Ann Thorac Surg. 2016;101:1921–7.CrossRefPubMed Huang PM, Kuo SW, Chen JS, Lee JM. Thoracoscopic mesh repair of diaphragmatic defects in hepatic Hydrothorax : a 10-year experience. Ann Thorac Surg. 2016;101:1921–7.CrossRefPubMed
40.
go back to reference Cerfolio RJ, Bryant AS. Efficacy of video-assisted thoracoscopic surgery with talc pleurodesis for porous diaphragm syndrome in patients with refractory hepatic hydrothorax. Ann Thorac Surg. 2006;82:457–9.CrossRefPubMed Cerfolio RJ, Bryant AS. Efficacy of video-assisted thoracoscopic surgery with talc pleurodesis for porous diaphragm syndrome in patients with refractory hepatic hydrothorax. Ann Thorac Surg. 2006;82:457–9.CrossRefPubMed
41.
go back to reference Hung TH, Tseng CW, Tsai CC, Tseng KC, Hsieh YH. The long-term outcomes of cirrhotic patients with pleural effusion. Saudi J Gastroenterol. 2018;24:46–51.CrossRefPubMedPubMedCentral Hung TH, Tseng CW, Tsai CC, Tseng KC, Hsieh YH. The long-term outcomes of cirrhotic patients with pleural effusion. Saudi J Gastroenterol. 2018;24:46–51.CrossRefPubMedPubMedCentral
Metadata
Title
International survey among hepatologists and pulmonologists on the hepatic hydrothorax: plea for recommendations
Authors
Jean-François David Cadranel
Isabelle Ollivier-Hourmand
Jacques Cadranel
Thierry Thevenot
Honoré Zougmore
Eric Nguyen-Khac
Christophe Bureau
Manon Allaire
Jean-Baptiste Nousbaum
Véronique Loustaud-Ratti
Xavier Causse
Philippe Sogni
Bertrand Hanslik
Marc Bourliere
Jean-Marie Peron
Nathalie Ganne-Carrie
Thong Dao
Dominique Thabut
Bernard. Maitre
Nabil Debzi
Ryad Smadhi
Roger Sombie
Raimi Kpossou
Olivier Nouel
Julien Bissonnette
Isaac Ruiz
Mourad Medmoun
Sergio Negrin Dastis
Pierre Deltenre
Florent Artru
Chantal Raherison
Laure Elkrief
Tristan Lemagoarou
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-02931-z

Other articles of this Issue 1/2023

BMC Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.